Loading the company…
Loading the company…
Families: CGM & insulin pump management.
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Deka Research And Development (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (2). The latest was on 2026-06-17.
| Family | Decisions on record |
|---|---|
| CGM & insulin pump management | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-06-17 | 510(k) | K261672 | twiist Automated Insulin Delivery (AID) System |
| 2024-05-24 | 510(k) | K241178 | DEKA ACE Pump System |
| 2024-03-13 | 510(k) | K233952 | DEKA ACE Pump System |
| 2023-07-25 | 510(k) | K213536 | DEKA ACE Pump System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Deka Research And Development.